Scienture Holdings (SCNX) Interest Coverage Ratio (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Interest Coverage Ratio came in at 10.01 in Q2 2026, down 26.79% year-over-year from 13.67 in Q2 2025, and up 89.44% quarter-over-quarter from 94.8 in Q1 2026.
Analysis
Scienture Holdings (SCNX) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Interest Coverage Ratio across 14 years of filings, most recently posting 10.01 for Q2 2026.
- In Q2 2026, Interest Coverage Ratio fell 26.79% year-over-year to 10.01; the TTM figure through Jun 2026 stood at 3.5 (up 40.73% YoY), while the FY2025 annual figure was 10.43, up 5.23% from the prior year.
- Interest Coverage Ratio came in at 10.01 for Q2 2026 at Scienture Holdings, up from 94.8 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.68 in Q3 2022 to a low of 710.1 in Q1 2022.
- Average Interest Coverage Ratio over 5 years is 96.15, with a median of 11.46 recorded in 2023.
- Year-over-year, Interest Coverage Ratio surged 99.27% in 2022 and slumped 9006.91% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 13.14 in 2022, then soared by 60.97% to 5.13 in 2023, then slumped by 5791.23% to 302.22 in 2024, then soared by 97.39% to 7.89 in 2025, then fell by 26.79% to 10.01 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 10.01 in Q2 2026, 94.8 in Q1 2026, and 7.89 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 0.05 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.02 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 1.87 |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -1.79 |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 5.97 |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 579.00 |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | -10.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.01 |
| Mar 31, 2026 | -94.80 |
| Jun 30, 2025 | -7.89 |
| Mar 31, 2025 | -5.32 |
| Jun 30, 2024 | -302.22 |
| Mar 31, 2024 | -55.76 |
| Dec 31, 2023 | -5.13 |
| Sep 30, 2023 | -3.36 |
| Jun 30, 2023 | -3.32 |
| Mar 31, 2023 | -12.92 |
| Dec 31, 2022 | -13.14 |
| Sep 30, 2022 | -1.68 |
| Jun 30, 2022 | -120.49 |
| Mar 31, 2022 | -710.10 |
| Dec 31, 2021 | -388.06 |
| Sep 30, 2021 | -230.55 |
| Jun 30, 2021 | -295.76 |
| Mar 31, 2021 | -88.69 |
| Dec 31, 2020 | -342.82 |
| Sep 30, 2020 | 19.63 |